...
search icon
nerv-img

Minerva Neurosciences Inc, Common Stock

NERV

NAQ

$1.46

+$0.01

(0.69%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$10.49M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
1.7683
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.48K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.15 L
$3.69 H
$1.46

About Minerva Neurosciences Inc, Common Stock

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNERVSectorS&P500
1-Week Return-2.67%-1.91%-1.87%
1-Month Return-17.98%-3.82%8.93%
3-Month Return-18.44%-11.56%-2.39%
6-Month Return-35.4%-10.21%-2.41%
1-Year Return-42.06%-9.91%10.88%
3-Year Return-49.31%-0.28%46.93%
5-Year Return-98.76%31.29%94.89%
10-Year Return-96.36%75.9%177.5%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue41.18M----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-101.79K8.51K30.98K-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.36,"profit":true},{"date":"2023-12-31","value":30.44,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit41.18M(101.79K)(8.51K)(30.98K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.25,"profit":false},{"date":"2022-12-31","value":-0.02,"profit":false},{"date":"2023-12-31","value":-0.08,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin100.00%(Infinity%)(Infinity%)(Infinity%)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses39.33M45.37M25.23M23.09M21.83M[{"date":"2020-12-31","value":86.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":55.62,"profit":true},{"date":"2023-12-31","value":50.89,"profit":true},{"date":"2024-12-31","value":48.11,"profit":true}]
Operating Income1.85M(45.37M)(25.23M)(23.12M)(21.85M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2456.52,"profit":false},{"date":"2022-12-31","value":-1366.26,"profit":false},{"date":"2023-12-31","value":-1251.91,"profit":false},{"date":"2024-12-31","value":-1183.07,"profit":false}]
Total Non-Operating Income/Expense94.02K(12.67M)(14.28M)(14.90M)18.73M[{"date":"2020-12-31","value":0.5,"profit":true},{"date":"2021-12-31","value":-67.67,"profit":false},{"date":"2022-12-31","value":-76.28,"profit":false},{"date":"2023-12-31","value":-79.6,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income1.94M(51.71M)(32.11M)(30.01M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2664.37,"profit":false},{"date":"2022-12-31","value":-1654.43,"profit":false},{"date":"2023-12-31","value":-1546.05,"profit":false},{"date":"2024-12-31","value":74.14,"profit":true}]
Income Taxes(94.02K)(1.80M)6.88M(2.00)-[{"date":"2020-12-31","value":-1.37,"profit":false},{"date":"2021-12-31","value":-26.22,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes2.03M(49.91M)(38.99M)(30.01M)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2452.63,"profit":false},{"date":"2022-12-31","value":-1915.97,"profit":false},{"date":"2023-12-31","value":-1474.61,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations1.94M(49.91M)(32.11M)(27.71M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2571.45,"profit":false},{"date":"2022-12-31","value":-1654.43,"profit":false},{"date":"2023-12-31","value":-1427.73,"profit":false},{"date":"2024-12-31","value":74.14,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income1.94M(49.91M)(38.99M)(30.01M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2571.45,"profit":false},{"date":"2022-12-31","value":-2008.79,"profit":false},{"date":"2023-12-31","value":-1546.05,"profit":false},{"date":"2024-12-31","value":74.14,"profit":true}]
EPS (Diluted)0.40(9.20)(6.02)(4.85)(3.32)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2300,"profit":false},{"date":"2022-12-31","value":-1505,"profit":false},{"date":"2023-12-31","value":-1212.5,"profit":false},{"date":"2024-12-31","value":-830,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NERV
Cash Ratio 7.57
Current Ratio 7.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NERV
ROA (LTM) -28.61%
ROE (LTM) -675.09%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NERV
Debt Ratio Lower is generally better. Negative is bad. 1.69
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.69

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NERV
Trailing PE 1.78
Forward PE 11.21
P/S (TTM) 1.87
P/B 2.68
Price/FCF NM
EV/R 0.03
EV/Ebitda 2.60
PEG NM

FAQs

What is Minerva Neurosciences Inc share price today?

Minerva Neurosciences Inc (NERV) share price today is $1.46

Can Indians buy Minerva Neurosciences Inc shares?

Yes, Indians can buy shares of Minerva Neurosciences Inc (NERV) on Vested. To buy Minerva Neurosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NERV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Minerva Neurosciences Inc be purchased?

Yes, you can purchase fractional shares of Minerva Neurosciences Inc (NERV) via the Vested app. You can start investing in Minerva Neurosciences Inc (NERV) with a minimum investment of $1.

How to invest in Minerva Neurosciences Inc shares from India?

You can invest in shares of Minerva Neurosciences Inc (NERV) via Vested in three simple steps:

  • Click on Sign Up or Invest in NERV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Minerva Neurosciences Inc shares
What is Minerva Neurosciences Inc 52-week high and low stock price?

The 52-week high price of Minerva Neurosciences Inc (NERV) is $3.69. The 52-week low price of Minerva Neurosciences Inc (NERV) is $1.15.

What is Minerva Neurosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Minerva Neurosciences Inc (NERV) is 1.7683

What is Minerva Neurosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Minerva Neurosciences Inc (NERV) is 2.68

What is the Market Cap of Minerva Neurosciences Inc?

The market capitalization of Minerva Neurosciences Inc (NERV) is $10.49M

What is Minerva Neurosciences Inc’s stock symbol?

The stock symbol (or ticker) of Minerva Neurosciences Inc is NERV

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top